A study published in the Annals of Internal Medicine Sept. 17 suggests daily aspirin could result in a net benefit for some people without established CVD, further muddying the debate over whether aspirin is an effective preventive tool for those without heart disease.

The incidence of CIED infection in the U.S. has been increasing for the past two decades, according to work published in JACC: Clinical Electrophysiology this month.

Just weeks after it fast-tracked dapagliflozin for the treatment of chronic kidney disease, the FDA announced it was granting Fast Track status to the drug for another indication: heart failure.

Patients who undergo partial breast radiation therapy after a lumpectomy are as satisfied with the outcome as those who undergo whole breast radiation therapy, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

The American Society of Nuclear Cardiology, together with eight other nuclear medicine and cardiology societies, have published a consensus document outlining the best practices for imaging and diagnosing cardiac amyloidosis.

High-dose, targeted radiation can be a safe and effective option for men with oligometastatic prostate cancer, according to findings presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO) in Chicago.

The FDA announced Sept. 13 it identified low levels of N-nitrosodimethylamine, or NDMA, in popular heartburn drugs including Zantac.

The American Society of Radiologic Technologists (ASRT) has announced its support of a new licensure bill introduced in the Pennsylvania House of Representatives.